U.S. subsidiary of Eastern Capital-backed Highland Therapeutics taps new president

Ironshore Pharmaceuticals (America) Inc., the U.S. subsidiary of pharmaceutical company Highland Therapeutics Inc., appointed Craig S. Lewis as president. Lewis, formerly SVP at Assurex Health, has been a member of IPA's board of directors since August 2015, and will retain that role. Highland is backed by Eastern Capital Limited, which led a $50 million financing in June 2015.

12 May 2016•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles